Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > Good use of paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs): the ANSM wants to strengthen the role of pharmacist’s advice

ANSM wants to strengthen the pharmacist’s advisory role for the use of Paracetamol and nonsteroidal anti-inflammatory drugs

admin 20 November 2019 All news
  • ← First vaccine to protect against Ebola
  • Regulators’ advice can make a difference for faster patient access to highly innovative therapies →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • Inclusion/exclusion criteria for the “Important Medical Events” list – EMA
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2020
  • Regulating medical devices from 1 January 2021
Copyright © 2018 - Pharmya - Legal terms - Quality Policy